Seulki Lee

Born in South Korea, Dr. Seulki Lee is a world-renowned researcher and nanotechnology expert. Seulki has worked on developing novel therapies for neurodegenerative disorders, cancer, and fibrosis diseases. Dr. Lee has been with Johns Hopkins School of Medicine since 2012, where they are currently an Associate Professor of Radiology.

Before joining Johns Hopkins, Dr. Lee worked at several other companies, including Neuraly, Inc., Precision Molecular, Inc., and Valted Seq, Inc. Seulki has also received multiple awards for their work, including the NRC Associateship from the National Academy of Sciences, the NIH Pathway to Independence Award (K99/R00), Career Development Award and Investigator-Initiated Research Award from the Department of Defense, Thome Memorial Foundation Award and the Maryland Innovation Initiative Award. In 2017, they were selected as a Highly Cited Researchers.

Seulki Lee earned their Doctor of Philosophy (Ph.D.) in Materials Science and Engineering from the Gwangju Institute of Science and Technology.

Some of their coworkers include Mohammad N. Ranjbar - Director, Bioinformatics, Anna Park - Business Development Manager, and Joshua Yang - Head of Business Development. Seulki Lee reports to Nina Urban, Interim CEO.